Skip to main content
SpringerLink
Log in

Hartfalen en COPD

  • Published:
Bijblijven

Samenvatting

Er is veel overlap tussen hartfalen en COPD wat betreft diagnostiek, etiologie, prognose en behandeling.

Bij iedereen met COPD dient men ook te denken aan hartfalen. Niet-herkend hartfalen komt bij deze groep patiënten veel voor. Er is ook veel overlap in klachten. Kortademigheid is een kernsymptoom voor beide ziekten. Piepende ademhaling en hoesten komen ook bij hartfalen voor, terwijl verminderde inspanningstolerantie en vermoeidheid ook veelgehoorde symptomen zijn bij patiënten met COPD.

Gemeenschappelijke oorzaken voor COPD en hartfalen zijn roken en systemische inflammatie. COPD en hartfalen zijn chronisch progressieve ziekten die elkaar in negatieve zin versterken. Cardioselectieve bètablokkers mogen wel worden voorgeschreven aan patiënten met COPD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatuur

  1. Mulrow CD, Lucey CR, Farnett LE. Discriminating causes of dyspnea through clinical examination. J Gen Intern Med. 1993;8:383–92.

    Article  PubMed  CAS  Google Scholar 

  2. Mourik Y van, Rutten FH, Moons KG, Bertens LC, Hoes AW, Reitsma JB. Prevalence and underlying causes of dyspnoea in older people: a systematic review. Age Ageing. 2014;43:319–26.

    Article  PubMed  Google Scholar 

  3. Riet EE van, Hoes AW, Limburg A, Landman MA, Hoeven H van der, Rutten FH. Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion. Eur J Heart Fail. 2014;16:772–7.

    Article  PubMed  CAS  Google Scholar 

  4. Valk MJ, Broekhuizen BD, Mosterd A, Zuithoff NP, Hoes AW, Rutten FH. COPD in patients with stable heart failure in the primary care setting. Int J Chron Obstruct Pulmon Dis. 2015;10:1219–24.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Brenner S, Güder G, Berliner D, Deubner N, Fröhlich K, Ertl G, Jany B, Angermann CE, Störk S. Airway obstruction in systolic heart failure – COPD or congestion? Int J Cardiol. 2013;168(3):1910–6.

    Article  PubMed  Google Scholar 

  6. Rutten FH, Cramer M‑JM, Grobbee DE, Sachs APE, Kirkels JH, Lammers J‑WJ, Hoes AW. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J. 2005;26:1887–94.

    Article  PubMed  Google Scholar 

  7. Güder G, Brenner S, Störk S, Hoes A, Rutten FH. Chronic obstructive pulmonary disease in heart failure: accurate diagnosis and treatment. Eur J Heart Fail. 2014;16(12):1273–82.

    Article  PubMed  Google Scholar 

  8. Thiadens HA, Bock GH de, Dekker FW, Huysman JA, Houwelingen JC van, Springer MP, et al. Identifying asthma and chronic obstructive pulmonary disease in patients with persistent cough presenting to general practitioners: descriptive study. BMJ. 1998;316:1286–90.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Kelder JC, Cramer MJ, Wijngaarden J van, Tooren R van, Mosterd A, Moons KG, Lammers JW, Cowie MR, Grobbee DE, Hoes AW. The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure. Circulation. 2011;124:2865–73.

    Article  PubMed  Google Scholar 

  10. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37:2893–962.

    Article  Google Scholar 

  11. Rutten FH, Cramer M‑JM, Lammers J‑WJ, Grobbee DE, Hoes AW. Heart failure and chronic obstructive pulmonary disease: an ignored combination? Eur J Heart Fail. 2006;8:706–11.

    Article  PubMed  Google Scholar 

  12. Rutten FH, Moons KCM, Cramer M‑JM, Grobbee DE, Zuithoff NPA, Lammers J‑WJ, Hoes AW. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ. 2005;331:1379–85.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Güder G, Brenner S, Angermann CE, Ertl G, Held M, Sachs APE, et al. GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study. Respir Res. 2012;13:13.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Güder G, Rutten FH, Brenner S, Angermann CE, Berliner D, Ertl G, Jany B, Lammers JWJ, Hoes AW, Störck S. The impact of heart failure on the classification of COPD severity. J Card Fail. 2012;18:637–44.

    Article  PubMed  Google Scholar 

  15. Sin DD, Man SF. Why are patients with COPD at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003;7:1514–9.

    Article  Google Scholar 

  16. Oudijk EJ, Lammers JW, Koenderman L. Systemic inflammation in chronic obstructive pulmonary disease. Eur Respir J Suppl. 2003;46:5s–13s.

    Article  PubMed  CAS  Google Scholar 

  17. Hole DJ, Watt GC, Davey S, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: findings from the Renfrew and paisley prospective population study. BMJ. 1996;313:711–5.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Zureik M, Kauffmann F, Touboul PJ, Courbon D, Ducimetiere P. Association between peak expiratory flow and the development of carotid atherosclerotic plaques. Arch Intern Med. 2001;161:1669–76.

    Article  PubMed  CAS  Google Scholar 

  19. Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, et al. Inflammatory markers and risk of heart failure in elderly subjects without prior infarction. Circulation. 2003;107:1486–91.

    Article  PubMed  CAS  Google Scholar 

  20. Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, et al. TOPCAT Investigators. Spironolactone for heart failure with preserved ejection fraction. N Engl J Med. 2014;370(15):1383–92.

    Article  PubMed  CAS  Google Scholar 

  21. Denus S de, O’Meara E, Desai AS, Claggett B, Lewis EF, Leclair G, et al. Spironolactone metabolites in TOPCAT – new insights into regional variation. N Engl J Med. 2017;376(17):1690–2.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Solomon SD, Claggett B, Lewis EF, Desai A, Anand I, Sweitzer NK, et al. TOPCAT Investigators. Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction. Eur Heart J. 2016;37(5):455–62.

    Article  PubMed  CAS  Google Scholar 

  23. Boudestein LC, Rutten FH, Cramer MJ, Lammers JW, Hoes AW. The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease. Eur J Heart Fail. 2009;11:1182–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Julius Centrum voor Eerstelijns Geneeskunde, UMC Utrecht, Universiteit van Utrecht, Utrecht, Nederland

    Frans H. Rutten

Authors
  1. Frans H. Rutten
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Frans H. Rutten.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rutten, F.H. Hartfalen en COPD. Bijblijven 34, 448–455 (2018). https://doi.org/10.1007/s12414-018-0328-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12414-018-0328-0

Search

Navigation